logo
Menu
  • Home
  • Company
    • Senior Management
    • Board of Directors
    • Careers
  • Pipeline
    • Levosimendan
      • Clinical Trials
    • Oxycyte
  • Research
    • LEVO-CTS Trial
      • LEVO-CTS Overview
      • LEVO-CTS Team
      • LEVO-CTS Training and Resources
    • Publications
      • Levosimendan in Cardiac Surgery
  • Investors
    • Corporate Profile
    • Press Releases
    • Corporate Governance
    • Board of Directors
    • Senior Management
    • Stock Information
    • Annual Reports
    • Analyst Coverage
    • SEC Filings
    • Events and Presentations
    • Investor Contacts
    • Tearsheet
    • Email Alerts
  • Media
    • Press Releases
  • Contact

Investor Contacts


John Mullaly
Managing Director
LifeSci Advisors, LLC
C: 617-429-3548
jmullaly@lifesciadvisors.com


  • Home
  • Company
    • Senior Management
    • Board of Directors
    • Careers
  • Pipeline
    • Levosimendan
      • Clinical Trials
    • Oxycyte
  • Research
    • LEVO-CTS Trial
      • LEVO-CTS Overview
      • LEVO-CTS Team
      • LEVO-CTS Training and Resources
    • Publications
      • Levosimendan in Cardiac Surgery
  • Investors
    • Corporate Profile
    • Press Releases
    • Corporate Governance
    • Board of Directors
    • Senior Management
    • Stock Information
    • Annual Reports
    • Analyst Coverage
    • SEC Filings
    • Events and Presentations
    • Investor Contacts
    • Tearsheet
    • Email Alerts
  • Media
    • Press Releases
  • Contact
© 2025 Tenax Therapeutics. All rights reserved.